Mark Gurney
@MarkGurneyOne
Followers
349
Following
2K
Statuses
137
Haematology SpR / Wellcome-HRB ICAT Fellow / ALMN Fellow Mayo Clinic 22-23
Dublin, Ireland
Joined January 2016
Thanks to all involved in our study of baseline factors which associated with subsequent myeloid neoplasms in adult CAR-T recipients. Intuitively, age ≥65 and baseline thrombocytopenia <140 defined the highest risk group in this @MayoClinic cohort.
5
7
44
RT @AlkaliDr: #BCOR impact in #MN by our group @Haematologica ⭐️⬇️ TP53 ⭐️⬆️ U2AF1 RUNX1 ⭐️⬇️ OS regardless of dz ⭐️ HCT ⬆️ OS unless RU…
0
6
0
Huge thank you to @MichaelodwyerMD @ICATProgramme @uniofgalway @clair_gardiner for the opportunity and support and examiners @Ullrich_Lab @aideenryan1 for the engaging viva examination!
@MarkGurneyOne all smiles after a successful defence of his PhD on engineering #CARNK for #AML. Thanks to @Ullrich_Lab @aideenryan1 and @mattgriffinneph for conducting exam @uniofgalway 👏
17
1
70
RT @MrinalPatnaik: TET2 somatic copy number alterations and allelic imbalances in #CMML. #4q24 #CNLOH #endoreduplic…
0
3
0
RT @HaemIreland: Abstract submission is open until 25th August. Looking forward to another meeting with high quality contents. https://t.co…
0
7
0
RT @RazonableMD: Mpox in solid organ transplant recipients: multicenter case series Mostly kidney recipients. Many with HIV infection. Hig…
0
32
0
RT @MrinalPatnaik: #TP53 allelic status and CN-LOH in #CMML -Infrequent but relevant. Isochromosome 17q with monocytosis associated with po…
0
5
0
RT @MayoClinicINFD: Congratulations to Dr. Eibhlin Higgins! After completing ID fellowship in Ireland, she was recruited for the subspecia…
0
6
0
RT @MayoHemeOnc: Our myeloid fellowship is open! This is a 1-year clinical + research program where heme/onc fellows gain additional experi…
0
5
0
RT @AlkaliDr: Our paper by @MarkGurneyOne on mutated #ETV6 myeloid neoplasms. Should it be one of the secondary mutations? #MDSsm #AMLsm…
0
7
0
RT @MrinalPatnaik: Clinical and Molecular Spectrum and Prognostic Outcomes of U2AF1 Mutan... #U2AF1 #Telomeres #Mal…
0
11
0
Putting on University of Galway colours for today to share our poster (4603) on TRAIL engineered NK cells with enhanced innate anti-leukemic activity in #AML, at #ASH2022 @MichaelodwyerMD @EvaSzegezdi @margaret_twohig @Eim_OReilly @OnkTherapeutics @ICATProgramme @CancerUniGalway
2
5
52
Looking forward to sharing our poster later today examining the characteristics of ETV6 mutated myeloid neoplasms at #ASH22. Special thanks to @AlkaliDr @ChekkafIsmahene @MayoCancerCare
4
5
43
0
0
3
RT @MichaelodwyerMD: CLL-1 CAR-NK with CISH KO for AML. Concurrent transposon engineering and CRISPR/Cas9 genome editing of pr... https://…
0
6
0
@sarahcormican91 @ICATProgramme @remedinuig @NUIGalwayMed @mattgriffinneph @hrbireland Huge congrats Sarah & Conor!!
0
0
1
RT @MichaelodwyerMD: Targeting hypersialylation in multiple #myeloma represents a novel approach to enhance #NK cell-mediated tumor respon…
0
8
0